| Devorah R Shagalov, MD | |
|
530 Fontaine St, Pensacola, FL 32503-2019 | |
| (800) 243-7546 | |
| (850) 484-8223 |
| Full Name | Devorah R Shagalov |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 11 Years |
| Location | 530 Fontaine St, Pensacola, Florida |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336584960 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | ME132450 (Florida) | Primary |
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | ME132450 (Florida) | Secondary |
| Entity Name | Associates In Dermatology, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316960297 PECOS PAC ID: 1355334863 Enrollment ID: O20040408000108 |
News Archive
GE Healthcare, a global leader in healthcare information technology, today announced Centricity Research, a new clinical research management solution (CRMS). Centricity Research will help improve the efficiency and efficacy of clinical research studies, enterprise-wide, by driving better management of treatment plans, processes, and protocols while supporting research billing compliance.
It looks like a real heart. And this is the goal of the first entirely soft artificial heart: to mimic its natural model as closely as possible.
More than 30 groups representing consumer, labor and Medicare beneficiaries have joined a growing coalition urging Congress to support transparency requirements for pharmacy benefit managers (PBMs) in the health care reform proposals being considered by Congress.
Hizentra (IgPro20) provides primary immunodeficiency (PI) patients with a safe and effective alternative to other immunoglobulin therapies when given in equivalent doses, according to Phase III pivotal trial data presented today at the XIVth Meeting of the European Society for Immunodeficiencies (ESID).
A new version of an obesity drug that caused serious psychiatric side effects could help people lose pounds without experiencing the anxiety, depression and suicidal thoughts previously associated with it. The research, published in Bioorganic and Medicinal Chemistry, shows that the new version of the drug can still work without reaching the brain in rats, avoiding the side effects.
› Verified 8 days ago
| Entity Name | Dermatology Associates Of The Palm Beaches Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649260308 PECOS PAC ID: 6709861602 Enrollment ID: O20040623001356 |
News Archive
GE Healthcare, a global leader in healthcare information technology, today announced Centricity Research, a new clinical research management solution (CRMS). Centricity Research will help improve the efficiency and efficacy of clinical research studies, enterprise-wide, by driving better management of treatment plans, processes, and protocols while supporting research billing compliance.
It looks like a real heart. And this is the goal of the first entirely soft artificial heart: to mimic its natural model as closely as possible.
More than 30 groups representing consumer, labor and Medicare beneficiaries have joined a growing coalition urging Congress to support transparency requirements for pharmacy benefit managers (PBMs) in the health care reform proposals being considered by Congress.
Hizentra (IgPro20) provides primary immunodeficiency (PI) patients with a safe and effective alternative to other immunoglobulin therapies when given in equivalent doses, according to Phase III pivotal trial data presented today at the XIVth Meeting of the European Society for Immunodeficiencies (ESID).
A new version of an obesity drug that caused serious psychiatric side effects could help people lose pounds without experiencing the anxiety, depression and suicidal thoughts previously associated with it. The research, published in Bioorganic and Medicinal Chemistry, shows that the new version of the drug can still work without reaching the brain in rats, avoiding the side effects.
› Verified 8 days ago
| Entity Name | Melissa Lazarus Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245416957 PECOS PAC ID: 6002986825 Enrollment ID: O20080605000759 |
News Archive
GE Healthcare, a global leader in healthcare information technology, today announced Centricity Research, a new clinical research management solution (CRMS). Centricity Research will help improve the efficiency and efficacy of clinical research studies, enterprise-wide, by driving better management of treatment plans, processes, and protocols while supporting research billing compliance.
It looks like a real heart. And this is the goal of the first entirely soft artificial heart: to mimic its natural model as closely as possible.
More than 30 groups representing consumer, labor and Medicare beneficiaries have joined a growing coalition urging Congress to support transparency requirements for pharmacy benefit managers (PBMs) in the health care reform proposals being considered by Congress.
Hizentra (IgPro20) provides primary immunodeficiency (PI) patients with a safe and effective alternative to other immunoglobulin therapies when given in equivalent doses, according to Phase III pivotal trial data presented today at the XIVth Meeting of the European Society for Immunodeficiencies (ESID).
A new version of an obesity drug that caused serious psychiatric side effects could help people lose pounds without experiencing the anxiety, depression and suicidal thoughts previously associated with it. The research, published in Bioorganic and Medicinal Chemistry, shows that the new version of the drug can still work without reaching the brain in rats, avoiding the side effects.
› Verified 8 days ago
| Entity Name | Shagalov Dermatology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972231405 PECOS PAC ID: 5991160244 Enrollment ID: O20230420002354 |
News Archive
GE Healthcare, a global leader in healthcare information technology, today announced Centricity Research, a new clinical research management solution (CRMS). Centricity Research will help improve the efficiency and efficacy of clinical research studies, enterprise-wide, by driving better management of treatment plans, processes, and protocols while supporting research billing compliance.
It looks like a real heart. And this is the goal of the first entirely soft artificial heart: to mimic its natural model as closely as possible.
More than 30 groups representing consumer, labor and Medicare beneficiaries have joined a growing coalition urging Congress to support transparency requirements for pharmacy benefit managers (PBMs) in the health care reform proposals being considered by Congress.
Hizentra (IgPro20) provides primary immunodeficiency (PI) patients with a safe and effective alternative to other immunoglobulin therapies when given in equivalent doses, according to Phase III pivotal trial data presented today at the XIVth Meeting of the European Society for Immunodeficiencies (ESID).
A new version of an obesity drug that caused serious psychiatric side effects could help people lose pounds without experiencing the anxiety, depression and suicidal thoughts previously associated with it. The research, published in Bioorganic and Medicinal Chemistry, shows that the new version of the drug can still work without reaching the brain in rats, avoiding the side effects.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Devorah R Shagalov, MD 9801 Collins Ave Apt 6s, Bal Harbour, FL 33154-1828 Ph: (347) 409-1660 | Devorah R Shagalov, MD 530 Fontaine St, Pensacola, FL 32503-2019 Ph: (800) 243-7546 |
News Archive
GE Healthcare, a global leader in healthcare information technology, today announced Centricity Research, a new clinical research management solution (CRMS). Centricity Research will help improve the efficiency and efficacy of clinical research studies, enterprise-wide, by driving better management of treatment plans, processes, and protocols while supporting research billing compliance.
It looks like a real heart. And this is the goal of the first entirely soft artificial heart: to mimic its natural model as closely as possible.
More than 30 groups representing consumer, labor and Medicare beneficiaries have joined a growing coalition urging Congress to support transparency requirements for pharmacy benefit managers (PBMs) in the health care reform proposals being considered by Congress.
Hizentra (IgPro20) provides primary immunodeficiency (PI) patients with a safe and effective alternative to other immunoglobulin therapies when given in equivalent doses, according to Phase III pivotal trial data presented today at the XIVth Meeting of the European Society for Immunodeficiencies (ESID).
A new version of an obesity drug that caused serious psychiatric side effects could help people lose pounds without experiencing the anxiety, depression and suicidal thoughts previously associated with it. The research, published in Bioorganic and Medicinal Chemistry, shows that the new version of the drug can still work without reaching the brain in rats, avoiding the side effects.
› Verified 8 days ago
Dr. Kevin L Welch, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8333 N Davis Hwy, West Florida Medical Center Clinic Pa, Pensacola, FL 32514 Phone: 850-474-8386 Fax: 850-474-8522 | |
Robert Macneal, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8333 N Davis Hwy, Pensacola, FL 32514 Phone: 850-474-8386 Fax: 850-474-8522 | |
Dr. Mary Foscue, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1601 E Heinberg St, Pensacola, FL 32502 Phone: 850-304-3997 Fax: 850-304-3997 | |
Mr. Boyd A Skinner, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1800 N E St, Pensacola, FL 32501 Phone: 850-434-3000 Fax: 850-469-8196 | |
William G Trent, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 312 Kenmore Rd, Pensacola, FL 32503 Phone: 850-471-7589 | |
Dr. David A Gaston Ii, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8333 N Davis Hwy, West Florida Medical Center Clinic Pa, Pensacola, FL 32514 Phone: 850-474-8386 Fax: 850-474-8522 | |
Justin L Shields Iii, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 540 Fontaine St, Pensacola, FL 32503 Phone: 850-484-4775 Fax: 850-484-4775 |